Celldex Therapeutics
CLDX
CLDX
85 hedge funds and large institutions have $11.3M invested in Celldex Therapeutics in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
51% less capital invested
Capital invested by funds: $23.2M → $11.3M (-$11.9M)
Holders
85
Holding in Top 10
2
Calls
$13K
Puts
–
Top Buyers
| 1 | +$1.2M | |
| 2 | +$256K | |
| 3 | +$243K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$56.9K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$47K |
Top Sellers
| 1 | -$383K | |
| 2 | -$347K | |
| 3 | -$286K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$141K |
| 5 |
ECM
Element Capital Management
New York
|
-$116K |